Tevogen TVGN
NASDAQ TVGN
$7.29 -0.05 (-0.68%)
At close: Sep 10, 2026 · 4:00 PM EDT

Tevogen (TVGN) Receivables - Other (2023 - 2026)

Tevogen's (TVGN) quarterly Receivables - Other came in at $158819.0 in Q2 2026, little changed on a YoY basis from $158819.0 in Q2 2025, and little changed quarter-over-quarter from $158819.0 in Q1 2026.

Analysis

Tevogen (TVGN) Receivables - Other (2023 - 2026) Analysis & Trends

Tevogen (TVGN) has reported Receivables - Other for 4 consecutive years, with $158819.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Receivables - Other changed 0.0% year-over-year to $158819.0; the trailing twelve-month figure through Jun 2026 stood at $158819.0 (changed 0.0% YoY), and the FY2025 full-year result was $158819.0, changed 0.0% from the prior year.
  • Receivables - Other was little changed at $158819.0 in Q2 2026 per TVGN's latest filing, from $158819.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $344500.0 in Q4 2023 and bottomed at $158819.0 in Q1 2024.
  • Historically, Receivables - Other has averaged $175699.1 across 4 years, with a median of $158819.0 in 2024.
  • The sharpest annual moves came in 2024 and 2025: Receivables - Other slumped 53.9% in 2024, then changed 0.0% in 2025.
  • Over 4 years, Receivables - Other stood at $344500.0 in 2023, then plunged by 53.9% to $158819.0 in 2024, then changed by 0.0% to $158819.0 in 2025, then changed by 0.0% to $158819.0 in 2026.
  • According to Business Quant data, Receivables - Other over the past three periods registered $158819.0, $158819.0, and $158819.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.21 Bn 9.37 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.04 Bn 5.04 Bn -
3 Iovance Biotherapeutics 3.65 Bn 3.36 Bn 55.72 Mn
4 Legend Biotech 3.54 Bn 2.57 Bn 251.50 Mn
5 uniQure 2.95 Bn 2.95 Bn 5.49 Mn
6 Beam Therapeutics 2.55 Bn 2.55 Bn -
7 Precigen 2.39 Bn 2.39 Bn 52.17 Mn
8 Sarepta Therapeutics 2.16 Bn 1.37 Bn 251.87 Mn
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn
10 Tevogen 27.76 Mn 27.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 158,819.00
Mar 31, 2026 158,819.00
Dec 31, 2025 158,819.00
Sep 30, 2025 158,819.00
Jun 30, 2025 158,819.00
Mar 31, 2025 158,819.00
Dec 31, 2024 158,819.00
Sep 30, 2024 158,819.00
Jun 30, 2024 158,819.00
Mar 31, 2024 158,819.00
Dec 31, 2023 344,500.00